These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 17261406

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group.
    Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, Smith R, Fletcher R.
    Circulation; 1993 Jun; 87(6 Suppl):VI5-16. PubMed ID: 8500240
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis.
    Kell R, Haunstetter A, Dengler TJ, Zugck C, Kübler W, Haass M.
    Eur Heart J; 2002 Jan; 23(1):70-8. PubMed ID: 11741364
    [Abstract] [Full Text] [Related]

  • 26. Usefulness of cardiac index and peak exercise oxygen consumption for determining priority for cardiac transplantation.
    Methvin A, Georgiopoulou VV, Kalogeropoulos AP, Malik A, Anarado P, Chowdhury M, Hussain I, Book WM, Laskar SR, Vega JD, Smith AL, Butler J.
    Am J Cardiol; 2010 May 01; 105(9):1353-5. PubMed ID: 20403492
    [Abstract] [Full Text] [Related]

  • 27. Value of the Bruce protocol to determine peak exercise oxygen consumption in patients evaluated for cardiac transplantation.
    Strzelczyk TA, Cusick DA, Pfeifer PB, Bondmass MD, Quigg RJ.
    Am Heart J; 2001 Sep 01; 142(3):466-75. PubMed ID: 11526360
    [Abstract] [Full Text] [Related]

  • 28. Prognostic value of cardiopulmonary exercise variables in chronic heart failure patients with or without beta-blocker therapy.
    Tabet JY, Metra M, Thabut G, Logeart D, Cohen-Solal A.
    Am J Cardiol; 2006 Aug 15; 98(4):500-3. PubMed ID: 16893705
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity.
    Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJ, Clark AL, Anker SD.
    J Card Fail; 2003 Feb 15; 9(1):29-35. PubMed ID: 12612870
    [Abstract] [Full Text] [Related]

  • 31. [Arrhythmia risk stratification based on clinical and functional data].
    Rostagno C, Lazzeri C, Gensini GF.
    Ital Heart J Suppl; 2001 Dec 15; 2(12):1270-7. PubMed ID: 11838347
    [Abstract] [Full Text] [Related]

  • 32. Four-variable risk model in men and women with heart failure.
    Chyu J, Fonarow GC, Tseng CH, Horwich TB.
    Circ Heart Fail; 2014 Jan 15; 7(1):88-95. PubMed ID: 24281135
    [Abstract] [Full Text] [Related]

  • 33. Clinical correlates of the myocardial force-frequency relationship in patients with end-stage heart failure.
    Hajjar RJ, DiSalvo TG, Schmidt U, Thaiyananthan G, Semigran MJ, Dec GW, Gwathmey JK.
    J Heart Lung Transplant; 1997 Nov 15; 16(11):1157-67. PubMed ID: 9402516
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cardiorespiratory response to exercise in men and women with obstructive sleep apnea.
    Cintra F, Poyares D, Rizzi CF, Risso TT, Skomro R, Montuori E, Mello-Fujita L, de Paola A, Tufik S.
    Sleep Med; 2009 Mar 15; 10(3):368-73. PubMed ID: 18706855
    [Abstract] [Full Text] [Related]

  • 36. Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison.
    Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA.
    Am Heart J; 2004 Feb 15; 147(2):354-60. PubMed ID: 14760336
    [Abstract] [Full Text] [Related]

  • 37. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
    Cygankiewicz I, Zareba W, Vazquez R, Bayes-Genis A, Pascual D, Macaya C, Almendral J, Fiol M, Bardaji A, Gonzalez-Juanatey JR, Nieto V, Valdes M, Cinca J, de Luna AB, MUSIC Investigators.
    Am J Cardiol; 2009 Apr 01; 103(7):1003-10. PubMed ID: 19327431
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Impact of optimal heart failure medical therapy on heart transplant listing.
    Geisberg C, Goring J, Listerman J, Nading MA, Huang RL, Butler J.
    Transplant Proc; 2006 Jun 01; 38(5):1493-5. PubMed ID: 16797340
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.